Westfield Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Westfield Capital Management's PFE Position: Q1 2026 in Review
Westfield Capital Management reduced its Pfizer (PFE) stake by 3% in Q1 2026, selling an estimated $112K and leaving 133,734 shares worth $3.76M. The position accounts for 0.02% of the portfolio, ranked #211.
Westfield Capital Management first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $110M in Q2 2013. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Westfield Capital Management held 133,734 shares of Pfizer worth $3.76M as of Q1 2026.
- Westfield Capital Management sold 4,202 Pfizer shares in Q1 2026, an estimated $112K.
- Pfizer made up 0.02% of Westfield Capital Management's portfolio in Q1 2026, its #211 holding.
- Westfield Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
- Westfield Capital Management's Pfizer position peaked at $110M in Q2 2013.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.